Literature DB >> 23860883

Use of ticagrelor in patients with ST-elevation myocardial infarction undergoing thrombolysis.

John Goudevenos1, Ioannis Ntalas, Ioanna Xanthopoulou, Kallirroi Kalantzi, Athanasios Pipilis, Dimitrios Alexopoulos.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 23860883     DOI： 10.1007/s11239-013-0972-2

Source DB:  PubMed          Journal:  J Thromb Thrombolysis        ISSN： 0929-5305            Impact factor:   2.300


× No keyword cloud information.
  5 in total

1.  2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.

Authors:  Patrick T O'Gara; Frederick G Kushner; Deborah D Ascheim; Donald E Casey; Mina K Chung; James A de Lemos; Steven M Ettinger; James C Fang; Francis M Fesmire; Barry A Franklin; Christopher B Granger; Harlan M Krumholz; Jane A Linderbaum; David A Morrow; L Kristin Newby; Joseph P Ornato; Narith Ou; Martha J Radford; Jacqueline E Tamis-Holland; Carl L Tommaso; Cynthia M Tracy; Y Joseph Woo; David X Zhao
Journal:  J Am Coll Cardiol       Date:  2012-12-17       Impact factor: 24.094

2.  P2Y12 platelet reactivity after thrombolytic therapy for ST-segment elevation myocardial infarction.

Authors:  Alejandro Diego; Armando Pérez de Prado; Carlos Cuellas; Antonio de Miguel; Beatriz Samaniego; David Alonso-Rodríguez; Roi Bangueses; Berta Vega; Julia Martín; Felipe Fernandez-Vazquez
Journal:  Thromb Res       Date:  2012-06-14       Impact factor: 3.944

3.  Randomized assessment of ticagrelor versus prasugrel antiplatelet effects in patients with ST-segment-elevation myocardial infarction.

Authors:  Dimitrios Alexopoulos; Ioanna Xanthopoulou; Vassilios Gkizas; George Kassimis; Konstantinos C Theodoropoulos; George Makris; Nikolaos Koutsogiannis; Anastasia Damelou; Grigorios Tsigkas; Periklis Davlouros; George Hahalis
Journal:  Circ Cardiovasc Interv       Date:  2012-11-20       Impact factor: 6.546

4.  Ticagrelor versus clopidogrel in patients with acute coronary syndromes.

Authors:  Lars Wallentin; Richard C Becker; Andrzej Budaj; Christopher P Cannon; Håkan Emanuelsson; Claes Held; Jay Horrow; Steen Husted; Stefan James; Hugo Katus; Kenneth W Mahaffey; Benjamin M Scirica; Allan Skene; Philippe Gabriel Steg; Robert F Storey; Robert A Harrington; Anneli Freij; Mona Thorsén
Journal:  N Engl J Med       Date:  2009-08-30       Impact factor: 91.245

5.  Comparison of prasugrel and ticagrelor loading doses in ST-segment elevation myocardial infarction patients: RAPID (Rapid Activity of Platelet Inhibitor Drugs) primary PCI study.

Authors:  Guido Parodi; Renato Valenti; Benedetta Bellandi; Angela Migliorini; Rossella Marcucci; Vincenzo Comito; Nazario Carrabba; Alberto Santini; Gian Franco Gensini; Rosanna Abbate; David Antoniucci
Journal:  J Am Coll Cardiol       Date:  2013-03-22       Impact factor: 24.094
  5 in total
  2 in total

1.  Ticagrelor versus high dose clopidogrel in ST-segment elevation myocardial infarction patients with high platelet reactivity post fibrinolysis.

Authors:  Dimitrios Alexopoulos; Angelos Perperis; Ioanna Koniari; Haralambos Karvounis; Sotirios Patsilinakos; Antonios Ziakas; Nikolaos Barampoutis; Theofilos Panagiotidis; Karolina Akinosoglou; George Hahalis; Ioanna Xanthopoulou
Journal:  J Thromb Thrombolysis       Date:  2015-10       Impact factor: 2.300

2.  Southern Saskatchewan Ticagrelor Registry experience.

Authors:  Payam Dehghani; Varun Chopra; Ali Bell; Sheila Kelly; Lori Zulyniak; Jeff Booker; Rodney Zimmermann; William Semchuk; Asim N Cheema; Andrea J Lavoie
Journal:  Patient Prefer Adherence       Date:  2014-10-16       Impact factor: 2.711
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.